Dr. Raghib Ali
FRCP MA(cantab) MA(oxon)
Raghib Ali is a Clinical Epidemiologist in the Cancer Epidemiology Unit, an Honorary Consultant in Acute Medicine at the John Radcliffe Hospital and Director of the INDOX Cancer Research Network. His main research interests are the aetiology, prevention & treatment of non-communicable diseases in Middle Eastern and South Asian populations. He is the principal investigator for a number of clinical trials and epidemiological studies including a case-control study of colorectal cancer in India looking at the association between life-long vegetarianism and colorectal cancer in India; a prospective cohort study investigating risk factors for diabetes in the UAE and a number of studies comparing the incidence of cancer in different ethnic groups in the UK.
He graduated in Medicine from Cambridge University in 1999 where he was awarded the John Addenbrooke’s prize for Medicine and also has postgraduate degrees from the Universities of Oxford and London. He completed his clinical training in General (Internal) Medicine and Clinical Pharmacology from the Oxford Deanery in 2009.
Danger ahead: the burden of diseases, injuries, and risk factors in the Eastern Mediterranean Region, 1990-2015.
GBD 2015 Eastern Mediterranean Region Collaborators None., (2018), Int J Public Health, 63, 11 - 23
Neonatal, infant, and under-5 mortality and morbidity burden in the Eastern Mediterranean region: findings from the Global Burden of Disease 2015 study.
GBD 2015 Eastern Mediterranean Region Neonatal, Infant, and under-5 Mortality Collaborators None., (2018), Int J Public Health, 63, 63 - 77
The UAE healthy future study: a pilot for a prospective cohort study of 20,000 United Arab Emirates nationals.
Abdulle A. et al, (2018), BMC Public Health, 18
The AGE-RAGE axis in an Arab population: The United Arab Emirates Healthy Futures (UAEHFS) pilot study
Inman CK. et al, (2017), Journal of Clinical & Translational Endocrinology, 10, 1 - 8
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators None., (2017), Lancet, 390, 1211 - 1259